NDC 63304-543-30 - Nefazodone hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63304-543
- Requested NDC
- 63304-543-30
- Package NDCs from labels
- 63304-543-30, 63304-543-05
- Manufacturer
- Ranbaxy Pharmaceuticals Inc.
- Effective date
- 2008-12-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nefazodone hydrochloride - Ranbaxy Pharmaceuticals Inc. | Ranbaxy Pharmaceuticals Inc. | 2008-12-24 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63304-543-05 | Nefazodone hydrochloride | 500 in 1 BOTTLE | TABLET | 500 | 1 | |
| 63304-543-30 | Nefazodone hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Nefazodone hydrochloride | ACTIVE INGREDIENT | 27X63J94GR | NEFAZODONE HYDROCHLORIDE TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | |
| nefazodone | ACTIVE MOIETY | 59H4FCV1TF | NEFAZODONE HYDROCHLORIDE TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | |
| colloidal silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | NEFAZODONE HYDROCHLORIDE TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | |
| ferric oxide (red and/or yellow) | INACTIVE INGREDIENT | NEFAZODONE HYDROCHLORIDE TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | ||
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | NEFAZODONE HYDROCHLORIDE TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | |
| microcrystalline cellulose | INACTIVE INGREDIENT | OP1R32D61U | NEFAZODONE HYDROCHLORIDE TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | |
| povidone | INACTIVE INGREDIENT | FZ989GH94E | NEFAZODONE HYDROCHLORIDE TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 | |
| sodium starch glycolate | INACTIVE INGREDIENT | NEFAZODONE HYDROCHLORIDE TABLET [RANBAXY PHARMACEUTICALS INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nefazodone Hydrochloride | NEFAZODONE HYDROCHLORIDE | Bryant Ranch Prepack | 0bd4c34a-4f43-4c84-8b98-1d074cba97d5 | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | 1098666 |
| Nefazodone Hydrochloride | NEFAZODONE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 51ff7db5-aaf9-4c3c-86e6-958ebf16b60f | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 1098649 1098666 1098670 1098674 1098678 |
| 5108CA5E-2AFE-5561-02A5-AF90B911698A | b1d149db-ad43-4f3f-aef1-fb0395ba4191 | 2008-12-24 | Boxed warning, Warnings, Adverse reactions | 5108CA5E-2AFE-5561-02A5-AF90B911698A b1d149db-ad43-4f3f-aef1-fb0395ba4191 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.